Page last updated: 2024-10-24

chlorambucil and Leukemoid Reaction

chlorambucil has been researched along with Leukemoid Reaction in 2 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Leukemoid Reaction: A peripheral blood picture resembling that of leukemia or indistinguishable from it on the basis of morphologic appearance alone. (Dorland, 27th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marie, J1
Hennequet, A1
Lévêque, B1
Debauchez, C1
Desbois, C1
Watchi, JM1
Barry, RE1
Salmon, PR1

Other Studies

2 other studies available for chlorambucil and Leukemoid Reaction

ArticleYear
[Histiocytic reticulosis in infants or Letterer-Siwe disease. (Clinical and therapeutical study)].
    Annales de pediatrie, 1968, Nov-02, Volume: 15, Issue:11

    Topics: Acrodermatitis; Betamethasone; Biopsy; Blood Cell Count; Bone Diseases; Child, Preschool; Chlorambuc

1968
Recurrent leukaemoid reaction in pernicious anaemia complicated by gastric carcinoma.
    British medical journal, 1969, Jun-07, Volume: 2, Issue:5657

    Topics: Adenocarcinoma; Anemia, Pernicious; Chlorambucil; Chronic Disease; Diagnosis, Differential; Female;

1969